Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
about
The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemiaSerologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maNovel Bruton's tyrosine kinase inhibitors currently in development.Monoclonal antibody-based therapeutics for leukemia.Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.Clinical potential of targeting Bruton's tyrosine kinase.Effects on bone metabolism of new therapeutic strategies with standard chemotherapy and biologic drugs.Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia.B-chronic lymphocytic leukemia chemoresistance involves innate and acquired leukemic side population cells.
P2860
Q24617708-EB505559-73CF-4340-B784-03379E1E1B79Q33779931-E628871E-E74D-43FD-8CB2-715E3FD6F228Q34008866-EE6DBD06-B462-4B10-9CC5-385A8A466E93Q35605318-DEFD7B40-8043-40BA-A012-66F2AB97BA8AQ36673755-35D427D5-61DF-4FC1-9535-D959FFB6006BQ36739759-C66BF9E7-F27C-44D6-A491-230A33EA82A2Q36843744-4D790C9F-300D-472C-8131-5481450CD6C6Q37094690-FC4D59F6-9925-4DBE-8C9A-E6F756C76ECBQ38189791-58B49E36-0E89-48E7-880F-01C8AFAC3A24Q39627268-8AA19662-622E-412D-8DEF-9F7C3A4CE27DQ41812846-5F584D87-9BB5-4F21-9497-7FE0955DAE17Q42912844-8C357E91-9AB6-46FE-B926-655FF3DDBB3B
P2860
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
@ast
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
@en
type
label
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
@ast
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
@en
prefLabel
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
@ast
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
@en
P1433
P1476
Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
@en
P2093
Michael R Grever
Thomas S Lin
P304
P356
10.1053/J.SEMINONCOL.2006.01.012
P50
P577
2006-04-01T00:00:00Z